BASEL, Switzerland, November 30 /PRNewswire/ -- The World Economic Forum today announced 39 visionary companies selected as Technology Pioneers 2008. Mondobiotech has been selected as one of these Technology Pioneers. The Technology Pioneers 2008 were nominated by the world's leading technology experts, including venture capitalists, technology companies, academics and media. The final selection from 273 nominees was made by a panel of leading technology experts appointed by the World Economic Forum. Technology Pioneers 2008 are invited to participate in the World Economic Forum Annual Meeting 2008 that will be held in Davos, Switzerland, from 23-27 January and in the Annual Meeting of the New Champions that will be held in Tianjin, People's Republic of China from 25-27 September 2008.
One of this year's Technology Pioneers is Mondobiotech, an independent, research engine biotech company focused on the development of treatment options for fatal and neglected rare diseases. It successfully develops human peptides to treat patients affected by rare diseases. This is done through its "search and development - S&D" method, access the global scientific know-how on potential therapeutics.
"This World Economic Forum Selection as a Technology Pioneer 2008 is an incredible honour for Mondobiotech and a validation of our unique business model," said Fabio Cavalli, CEO of Mondobiotech.
"As this is the first year a Swiss biotech receives this prestigious award, we are especially pleased to be granted this international recognition. This prize clearly supports our mission to change the world in healthcare and find the cure for an increasing number of the 7,000 neglected diseases in the near future."
Technology Pioneers are companies that have been identified as
developing and applying highly transformational and innovative technologies
in the areas of energy, biotechnology and health, and information
technology. To be selected as a Technology P
|SOURCE Mondobiotech AG|
Copyright©2007 PR Newswire.
All rights reserved